User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Schliemann, C.; Pink, D.; Floercken, A.; Ahrens, M.; Egerer, G.; Goetze, K.; Palmerini, E.; Stacchiotti, S.; Grignani, G.; Rutkowski, P.; Ullrich, R.; Strapatsas, J.; Hemmerle, T.; Neri, D.; Kessler, T.
Title:
A phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma
Journal title abbreviation:
Ann Oncol
Year:
2021
Journal volume:
32 Suppl 5
Pages contribution:
S1127-S1127
Fulltext / DOI:
doi:10.1016/j.annonc.2021.08.883
Print-ISSN:
0923-7534
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX